U.S., Feb. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07440225) titled 'A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)' on Feb. 23.
Brief Summary: Researchers are looking for new ways to treat neovascular age-related macular degeneration (NVAMD).
Available standard (usual) treatments for NVAMD, such as aflibercept, may not work for every person. Researchers want to learn if a trial medicine called tiespectus (also called MK-8748 or EYE201) can treat NVAMD.
The goal of this trial is to learn if tiespectus works as well as aflibercept to treat NVAMD.
Study Start Date: March 31
Study Type: INTERVENTIONAL
Condition:
Macular Degeneration
Age-Related Macular Degener...